Melatonin is one of the most popular sleep-support ingredients in the global supplement market. But if you're planning to launch a melatonin product in the European Union, the regulatory landscape is more complex than you might expect.
The Core Challenge: Novel Food Classification
In the EU, melatonin is classified as a Novel Food under Regulation (EU) 2015/2283. This means any melatonin-containing supplement requires Novel Food authorization before it can be legally marketed — unless it was on the market before May 1997 (the Novel Food cut-off date).
The practical implication: a generic Novel Food application can cost €50,000–€300,000 and take 18–36 months. This is a significant barrier for smaller founder-led brands.
Dosage Limits: A Fragmented Landscape
Even where melatonin is permitted, maximum daily doses vary dramatically:
| Member State | Max Daily Dose | Classification | Notes |
|---|---|---|---|
| Germany | 1 mg | Food Supplement | Requires Novel Food authorization |
| Spain | 1.9 mg | Food Supplement | Limited product categories |
| Italy | 1 mg | Food Supplement | Notification required |
| France | 2 mg | Food Supplement | ANSES safety opinion influenced limits |
| Netherlands | 0.3 mg | Food Supplement | Very restrictive |
| UK (post-Brexit) | 1 mg | Food Supplement | GB Novel Foods list applies |
| Poland | 1 mg | Food Supplement | Growing market, active enforcement |
Strategy for Brand Founders
Option 1: Sub-1mg Formulation (Broadest Market Access)
Formulate at ≤0.3mg to cover the most restrictive markets (Netherlands). This limits your efficacy positioning but maximizes regulatory coverage.
Option 2: Multi-SKU Approach
Develop 1mg (core EU), 2mg (France), and 0.3mg (Netherlands) variants. More complex supply chain but allows market-specific claims.
Option 3: Alternative Sleep Ingredients
Consider non-Novel-Food alternatives:
- Magnesium bisglycinate — Well-established, no Novel Food issues
- L-theanine — Generally recognized, relaxation positioning
- Chamomile / Valerian extracts — Traditional use, food ingredient status
- 5-HTP (Griffonia extract) — Available in several EU markets with less restriction
Enforcement Trends
EU member states have been increasing enforcement on unauthorized melatonin products. In 2025, German authorities issued over 40 warning letters to brands selling melatonin above 1mg or without proper authorization. The days of flying under the radar are ending.
How SuppBridge Helps
We work with regulatory consultants in key EU markets to evaluate your formulation against the latest requirements. For melatonin specifically, we can:
- Map your target markets against current dosage limits
- Identify the optimal per-serving dose for maximum EU coverage
- Connect you with Novel Food application support if needed
- Recommend alternative ingredient strategies where regulatory barriers are too high
Have questions about EU supplement regulations? Contact our team →
Ready to turn insights into action?
Start a Conversation →